(Q44430821)

2 December 2017

title

Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis (English)

1 reference

2 December 2017

Branka Zegura

1

1 reference

2 December 2017

Irena Keber

series ordinal

2

1 reference

2 December 2017

Miran Sebestjen

series ordinal

3

1 reference

2 December 2017

Wolfgang Koenig

series ordinal

4

1 reference

2 December 2017

publication date

1 May 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

168

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

123-129

1 reference

Menopause and coronary heart disease. The Framingham Study

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Early menopause and the risk of myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

On some Late Effects of Bilateral Oophorectomy in the Age Range 15–30 Years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Hormone replacement therapy and increased plasma concentration of C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Biologic effects of transdermal estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Elevated C-reactive protein levels in overweight and obese adults

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Prospective evaluation of the systemic immune response following abdominal, vaginal, and laparoscopically assisted vaginal hysterectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

MicroCRP: a highly sensitive CRP method applied in the monitoring of renal allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

Coagulation activation following estrogen administration to postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

EFFECTS OF ESTROGEN REPLACEMENT THERAPY ON THROMBIN GENERATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900088-1

10.1016/S0021-9150(03)00088-1

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference